Matches in SemOpenAlex for { <https://semopenalex.org/work/W2911991391> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W2911991391 endingPage "e14328" @default.
- W2911991391 startingPage "e14328" @default.
- W2911991391 abstract "Lung cancer is the leading cause of cancer-associated deaths all over the world. Although the prognosis of lung cancer has improved over the past decade due to progression in surgical techniques and systematic treatments, the patients with advanced disease still suffer poor survival. There are no standard treatment strategies for patients who have failed to respond to at least 2 lines of chemotherapy in non-small cell lung cancer (NSCLC). Apatinib, one of the latest small-molecule oral anti-angiogenesis targeted agents developed first in China, has shown remarkable anti-tumor efficacy in a variety of solid tumor types.A 72-year-old woman underwent radical resection of the left lung cancer in July 2011, but was found a recurrence of cancer after 2 years.The histopathological examination of the resected specimen identified the lesion as lung adenocarcinoma.She received gemcitabine and carboplatin regimen as adjuvant chemotherapy for 4 cycles following the surgery in August 2011. After the tumor relapsed, she received multiple lines of chemotherapy including paclitaxel, cisplatin, docetaxel, and gemcitabine from July 2013, but still suffered progressive disease in February 2017. Then apatinib alone was used to defend against the tumor at a dose of 250 mg/d orally till December 2017.The efficacy was assessed as partial response 1 month later in March 2017. And the use of apatinib was continued till the patient died of tumor progression, achieving a progression-free survival for 10 months. During the treatment with apatinib, the patient experienced hypertension of grade 1, which was well-tolerated and manageable.Apatinib might be efficient and well-tolerated for patients with advanced NSCLC who have failed to respond to multi-line treatments, even at a low dose." @default.
- W2911991391 created "2019-02-21" @default.
- W2911991391 creator A5006250732 @default.
- W2911991391 creator A5070745750 @default.
- W2911991391 creator A5074469145 @default.
- W2911991391 date "2019-02-01" @default.
- W2911991391 modified "2023-09-25" @default.
- W2911991391 title "Low dose of apatinib in treating chemotherapy and EGFR-TKI refractory non-small cell lung cancer" @default.
- W2911991391 cites W1816099873 @default.
- W2911991391 cites W1978139448 @default.
- W2911991391 cites W1981186476 @default.
- W2911991391 cites W2000082608 @default.
- W2911991391 cites W2105968397 @default.
- W2911991391 cites W2110342205 @default.
- W2911991391 cites W2276228008 @default.
- W2911991391 cites W2341695670 @default.
- W2911991391 cites W2578710297 @default.
- W2911991391 cites W2601341257 @default.
- W2911991391 cites W2607941874 @default.
- W2911991391 cites W2745144228 @default.
- W2911991391 cites W2747382292 @default.
- W2911991391 cites W2772987978 @default.
- W2911991391 cites W2791249304 @default.
- W2911991391 cites W785602768 @default.
- W2911991391 doi "https://doi.org/10.1097/md.0000000000014328" @default.
- W2911991391 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6380768" @default.
- W2911991391 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30702616" @default.
- W2911991391 hasPublicationYear "2019" @default.
- W2911991391 type Work @default.
- W2911991391 sameAs 2911991391 @default.
- W2911991391 citedByCount "3" @default.
- W2911991391 countsByYear W29119913912019 @default.
- W2911991391 countsByYear W29119913912021 @default.
- W2911991391 crossrefType "journal-article" @default.
- W2911991391 hasAuthorship W2911991391A5006250732 @default.
- W2911991391 hasAuthorship W2911991391A5070745750 @default.
- W2911991391 hasAuthorship W2911991391A5074469145 @default.
- W2911991391 hasBestOaLocation W29119913911 @default.
- W2911991391 hasConcept C121608353 @default.
- W2911991391 hasConcept C126322002 @default.
- W2911991391 hasConcept C141071460 @default.
- W2911991391 hasConcept C143998085 @default.
- W2911991391 hasConcept C2776256026 @default.
- W2911991391 hasConcept C2776694085 @default.
- W2911991391 hasConcept C2778239845 @default.
- W2911991391 hasConcept C2778822529 @default.
- W2911991391 hasConcept C2780258809 @default.
- W2911991391 hasConcept C2780668389 @default.
- W2911991391 hasConcept C2781190966 @default.
- W2911991391 hasConcept C2781413609 @default.
- W2911991391 hasConcept C2781451048 @default.
- W2911991391 hasConcept C71924100 @default.
- W2911991391 hasConceptScore W2911991391C121608353 @default.
- W2911991391 hasConceptScore W2911991391C126322002 @default.
- W2911991391 hasConceptScore W2911991391C141071460 @default.
- W2911991391 hasConceptScore W2911991391C143998085 @default.
- W2911991391 hasConceptScore W2911991391C2776256026 @default.
- W2911991391 hasConceptScore W2911991391C2776694085 @default.
- W2911991391 hasConceptScore W2911991391C2778239845 @default.
- W2911991391 hasConceptScore W2911991391C2778822529 @default.
- W2911991391 hasConceptScore W2911991391C2780258809 @default.
- W2911991391 hasConceptScore W2911991391C2780668389 @default.
- W2911991391 hasConceptScore W2911991391C2781190966 @default.
- W2911991391 hasConceptScore W2911991391C2781413609 @default.
- W2911991391 hasConceptScore W2911991391C2781451048 @default.
- W2911991391 hasConceptScore W2911991391C71924100 @default.
- W2911991391 hasIssue "5" @default.
- W2911991391 hasLocation W29119913911 @default.
- W2911991391 hasLocation W29119913912 @default.
- W2911991391 hasLocation W29119913913 @default.
- W2911991391 hasLocation W29119913914 @default.
- W2911991391 hasOpenAccess W2911991391 @default.
- W2911991391 hasPrimaryLocation W29119913911 @default.
- W2911991391 hasRelatedWork W2036431359 @default.
- W2911991391 hasRelatedWork W2176768908 @default.
- W2911991391 hasRelatedWork W2360834723 @default.
- W2911991391 hasRelatedWork W2373050420 @default.
- W2911991391 hasRelatedWork W2380347422 @default.
- W2911991391 hasRelatedWork W2386316807 @default.
- W2911991391 hasRelatedWork W2417620129 @default.
- W2911991391 hasRelatedWork W2980512133 @default.
- W2911991391 hasRelatedWork W2993175924 @default.
- W2911991391 hasRelatedWork W2125019270 @default.
- W2911991391 hasVolume "98" @default.
- W2911991391 isParatext "false" @default.
- W2911991391 isRetracted "false" @default.
- W2911991391 magId "2911991391" @default.
- W2911991391 workType "article" @default.